Search clinical trials for: Lyophilized S95014

Total 110 results

Institut de Recherches Internationales Servier
ADIR, a Servier Group company; Les Laboratoires Servier (L.L.S), Russia

Completed

A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) (ALL)

Acute Lymphoblastic Leukemia

Russian Federation
Institut de Recherches Internationales Servier
ADIR, a Servier Group company; Les Laboratoires Servier (L.L.S), Russia

Completed

A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL) (ALL)

Acute Lymphoblastic Leukemia

Russian Federation
Servier Bio-Innovation LLC
Regeneron Pharmaceuticals; Institut de Recherches Internationales Servier

Not yet recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer (NSCLC)
University of Alberta
University of British Columbia; McGill University; University of Calgary

Active, not recruiting

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

Clostridium Difficile Diarrhea | Clostridia Difficile Colitis

Canada
China Academy of Chinese Medical Sciences
National Natural Science Foundation of China

Recruiting

Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure (AUGUST-AHF)

Acute Heart Failure | Chinese Medicine | Complementary Medicine

China
NICHD Global Network for Women's and Children's...
University of Colorado, Denver; University of Alabama at Birmingham; University... and other collaborators

Completed

First Bites: Complementary Feeding - A Global Network Cluster Randomized Controlled Trial (First Bites)

Complementary Feeding | Infant Growth

Congo, Guatemala, Pakistan, Zambia
Vancouver Island Health Authority

Unknown

Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection

Canada
The University of Texas Health Science Center,...
Kelsey Research Foundation; Roderick MacDonald Research Fund at Baylor St.... and other collaborators

Completed

Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route

C. Difficile

United States
Federal University of São Paulo
University of Sao Paulo; Sorocaba Eye Bank

Completed

Lamellar Transplant With Lyophilized Corneas

Keratoconus

Brazil
HemCon Medical Technologies, Inc

Completed

The Safety of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Healthy Volunteers

Healthy

United States
Windtree Therapeutics
Momentum Research, Inc.

Active, not recruiting

The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (SEISMiC)

Cardiogenic Shock

United States, Italy, Poland, Argentina
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Clinical Study of IBI362 in Healthy Chinese Male Subjects

Overweight/Obesity

China
University of Sao Paulo

Unknown

Comparative Study Between Lyophilized or Frozen Bone Allografts for Sinus-lifting

Disorder of Maxillary Sinus | Accessory; Bone | Bone Atrophy
University of Southampton
University Hospital Southampton NHS Foundation Trust

Unknown

A Controlled Study to Assess Safety, Colonisation and Immunogenicity of Reconstituted Lyophilised Neisseria Lactamica (Lac5-Nasal)

Meningitis, Bacterial

United Kingdom
GlaxoSmithKline

Completed

Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants

Rotavirus

India
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Recruiting

Calaspargase Pegol in Adults With ALL

Acute Lymphoblastic Leukemia

United States
THEVAX Genetics Vaccine
Clinical Research Management, Inc.

Unknown

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

Human Papillomavirus | High-Grade Squamous Intraepithelial Lesions

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Air Force Military Medical University, China; Guangxi Center for Disease Control... and other collaborators

Completed

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

Tuberculosis

China
Sanofi
Regeneron Pharmaceuticals

Completed

Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers

Hypercholesterolemia

Japan
HemCon Medical Technologies, Inc

Withdrawn

A Clinical Study of Lyophilized Plasma in Patients on Warfarin

Anticoagulant Therapy
HemCon Medical Technologies, Inc

Withdrawn

Clinical Study of Lyophilized Plasma in Patients With Liver Disease

Liver Disease
Bristol-Myers Squibb

Completed

A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors

Cancer | Tumor

United States, Spain, Canada, France
Bristol-Myers Squibb

Completed

Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors

Cancer

Japan
University of Alberta

Recruiting

LFMT vs Placebo in New Biologic Start for Ulcerative Colitis

Ulcerative Colitis

Canada
University of Minnesota

Recruiting

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
French Defence Health Service
Institut de Recherche Biomedicale des Armees; Hôpital Edouard Herriot; Henri... and other collaborators

Completed

Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO) (PREHO-PLYO)

Shock Hemorrhagic

France
Changchun BCHT Biotechnology Co.

Not yet recruiting

To Explore a Bridging Index for the Effectiveness of the Clinical Trial

Randomized
Wuhan Rhegen Biotechnology Co., Ltd.
Shenzhen Rhegen Biotechnology Co., Ltd.; Wuhan Recogen Biotechnology Co., Ltd.

Withdrawn

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

COVID-19 Pandemic
Duke University
U.S. Highbush Blueberry Council

Completed

Effect of Blueberry Supplementation on Alzheimer's Biomarkers

Alzheimer Disease | Mild Cognitive Impairment

United States
Bristol-Myers Squibb

Completed

Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX

Cancer

United States, France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers

Cardiovascular Diseases

Belgium
Servier
Servier Pharmaceuticals, LLC

Available

Vorasidenib Expanded Access Program

Pathologic Processes | Glioma | Neoplasms | Neoplasms by Histologic Type | Neoplasms, Glandular and Epithelial | Recurrence | Disease Attributes | Neoplasms, Germ Cell and Embryonal | Neoplasms, Neuroepithelial | Neuroectodermal Tumors | Neoplasms, Nerve Tissue
Bausch & Lomb Incorporated

Completed

Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

Pain

United States
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Recruiting

Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

Advanced Solid Tumor

Netherlands
GlaxoSmithKline

Active, not recruiting

A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody

Multiple Myeloma

United States, Spain, France, Germany, Australia, United Kingdom, Canada, Italy
Bristol-Myers Squibb

Completed

Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response

Non-Small-Cell Lung Carcinoma

Japan
Servier Bio-Innovation LLC
Institut de Recherches Internationales Servier

Recruiting

A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors

Solid Tumor

Spain, Australia, Belgium, United States
Wuhan Recogen Biotechnology Co., Ltd.

Withdrawn

Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA Vaccine

COVID-19 Pandemic
Bristol-Myers Squibb

Completed

Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects

Cancer

Switzerland
GlaxoSmithKline

Completed

A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug

Asthma

United States, United Kingdom, Germany
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

Primary Sjögren's Syndrome

United States, France, United Kingdom, Australia, Germany, Hungary, Spain
Dongzhimen Hospital, Beijing
Tianjin University of Traditional Chinese Medicine

Recruiting

Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke (EXPECT)

Acute Ischemic Stroke

China
Myanmar Oxford Clinical Research Unit
University of Oxford; Mahidol Oxford Tropical Medicine Research Unit

Suspended

Optimal Dose of Antivenom for Daboia Siamensis Envenomings (ODADS)

Daboia Siamensis Envenoming

Myanmar
MedImmune LLC

Completed

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Chronic Lung Disease

United States
Vac4All
Radboud University Medical Center; Centre Hospitalier Universitaire Vaudois; European...

Unknown

Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage) (PEBS-POC1)

Malaria

Switzerland
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

Metastatic Colorectal Cancer

Russian Federation
Takeda

Completed

Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

Dengue Fever

United States
Bristol-Myers Squibb

Completed

A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin

Cancer (Solid Tumors)

United Kingdom, United States, Canada
Hospital General de Mexico

Completed

Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)

Irritable Bowel Syndrome With Diarrhea

Mexico
Amit Agrawal

Completed

Freeze-Dried Black Raspberries in Treating Patients With Oral Squamous Cell Cancer Undergoing Surgery

Squamous Cell Carcinoma of Mouth

United States

Search clinical trials for: Lyophilized S95014

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations